activation of innate immune response |
Any process that initiates an innate immune response. Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. Examples of this process include activation of the hypersensitive response of Arabidopsis thaliana and activation of any NOD or TLR signaling pathway in vertebrate species. |
cellular response to exogenous dsRNA |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an exogenous double-stranded RNA stimulus. |
defense response to bacterium |
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism. |
defense response to virus |
Reactions triggered in response to the presence of a virus that act to protect the cell or organism. |
innate immune response |
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
negative regulation of viral genome replication |
Any process that stops, prevents, or reduces the frequency, rate or extent of viral genome replication. |
positive regulation of chemokine (C-C motif) ligand 5 production |
Any process that activates or increases the frequency, rate, or extent of production of chemokine (C-C motif) ligand 5. |
positive regulation of defense response to virus by host |
Any host process that results in the promotion of antiviral immune response mechanisms, thereby limiting viral replication. |
positive regulation of DNA-binding transcription factor activity |
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
positive regulation of interferon-alpha production |
Any process that activates or increases the frequency, rate, or extent of interferon-alpha production. |
positive regulation of interferon-beta production |
Any process that activates or increases the frequency, rate, or extent of interferon-beta production. |
positive regulation of interleukin-6 production |
Any process that activates or increases the frequency, rate, or extent of interleukin-6 production. |
positive regulation of interleukin-8 production |
Any process that activates or increases the frequency, rate, or extent of interleukin-8 production. |
positive regulation of IP-10 production |
Any process that activates or increases the frequency, rate, or extent of production of IP-10. |
positive regulation of myeloid dendritic cell cytokine production |
Any process that activates or increases the frequency, rate, or extent of myeloid dendritic cell cytokine production. |
positive regulation of protein import into nucleus |
Any process that activates or increases the frequency, rate or extent of movement of proteins from the cytoplasm into the nucleus. |
positive regulation of protein phosphorylation |
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
positive regulation of response to cytokine stimulus |
Any process that increases the rate, frequency, or extent of a response to cytokine stimulus. |
positive regulation of transcription by RNA polymerase II |
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
positive regulation of tumor necrosis factor production |
Any process that activates or increases the frequency, rate or extent of tumor necrosis factor production. |
positive regulation of type I interferon production |
Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
positive regulation of type I interferon-mediated signaling pathway |
Any process that increases the rate, frequency or extent of a type I interferon-mediated signaling pathway. |
regulation of peroxisome organization |
Any process that modulates the frequency, rate or extent of peroxisome organization. |
RIG-I signaling pathway |
The series of molecular signals initiated by the binding of viral RNA to a pattern recognition receptor (PRR) RIG-1 (also known as DDX58). RIG-I is a cytoplasmic receptor that detects RNA synthesized during viral replication and triggers a signaling pathway to protect the host against viral infection, for example by inducing the expression of antiviral cytokines. |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |